<DOC>
	<DOCNO>NCT01559714</DOCNO>
	<brief_summary>Study population : 1 ) mutation carrier without hypertrophic phenotype ( pre-clinical Hypertrophic Cardiomyopathy ( HCM ) ) 2 ) patient clinically overt HCM ( clinical HCM ) . Hypothesis : Cardiac troponin release exercise demonstrate clinical pre-clinical HCM patient .</brief_summary>
	<brief_title>A Biomarker MRI Study Troponin Release After Exercise Hypertrophic Cardiomyopathy</brief_title>
	<detailed_description />
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<criteria>Patients echocardiographically proven hypertrophic cardiomyopathy accord ESC guideline individual HCM associate mutation without clinical characteristic hypertrophic cardiomyopathy ( preclinical HCM patient ) ; Age â‰¥ 18 year ; Able comply protocol ; Written inform consent . Known significant epicardial coronary artery disease ; Patients LVH clinical setting disorder explain myocardial hypertrophy ( amyloidosis , MELAS , AndersonFabry , WPW etc . ) ; Heart failure NYHA class IIIIV ; Patients know hemodynamic instability syncope exercise due leave ventricular outflow gradient occurrence ventricular arrhythmia ; History PTSMA ( percutaneous transluminal septal myocardial ablation ) Morrow myectomy ; Patients able complete bicycle test ; Any contraindication MR imaging ( MR image obligatory assessment primary objective , therefore relative exclusion criterion ) ; Recent ( within 30 day ) admittance hospital cardiac reason ( myocardial infarction , heart failure , cardiac arrhythmia , etc . ) ; Severe renal insufficiency ( eGFR &lt; 30 ml/min ) ; Any condition , opinion investigator , may pose significant hazard subject participate present study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Troponin</keyword>
	<keyword>Exercise</keyword>
	<keyword>MRI</keyword>
</DOC>